This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Zacks Analyst Blog Highlights: RCI Hospitality, Great Lakes Dredge & Dock, CoDiagnostics, Sportsman's Warehouse and Resources Connection
by Zacks Equity Research
The Zacks Analyst Blog Highlights: RCI Hospitality, Great Lakes Dredge & Dock, CoDiagnostics, Sportsman's Warehouse and Resources Connection
Has CoDiagnostics (CODX) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Here's How to Play May's Stunning Jobs Report
by Tirthankar Chakraborty
A mind-boggling 2.5 million were employed in May, in contrast to several economists' apprehensions of a loss of 7.25 million jobs. Here's how to play May's surprising jobs gain -
Top Ranked Momentum Stocks to Buy for June 5th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 5th.
Find Strong Buy Stocks for the Coronavirus Market Rally with this Screener
by Benjamin Rains
Zacks Rank #1 (Strong Buy) stocks outperform the market in both good and bad times. However, there are over 200 stocks that earn a Zacks Rank #1 at any given time...
5 Stocks to Bank on May's Strong Market Rally
by Zacks Equity Research
Stocks made a comeback in May, as major indexes marched higher on the economy gathering steam, government's stimulus measures and optimism over a potential vaccine for coronavirus.
Top Ranked Momentum Stocks to Buy for May 27th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 27th
Co-Diagnostics (CODX): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Co-Diagnostics (CODX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Co-Diagnostics' Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Co-Diagnostics.
Can CoDiagnostics, Inc. (CODX) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CoDiagnostics, Inc. (CODX) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is CoDiagnostics (CODX) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Are Options Traders Betting on a Big Move in Co-Diagnostics (CODX) Stock?
by Zacks Equity Research
Investors need to pay close attention to Co-Diagnostics (CODX) stock based on the movements in the options market lately.
CoDiagnostics, Inc. (CODX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -25.00% and 40.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
CoDiagnostics Inc (CODX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CoDiagnostics Inc (CODX) closed at $17.11 in the latest trading session, marking a +0.38% move from the prior day.
Is Co-Diagnostics (CODX) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
Company News for Apr 21, 2020
by Zacks Equity Research
Companies In The News Are: CYCC, CODX, NBY, EXEL
Implied Volatility Surging for Co-Diagnostics (CODX) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Co-Diagnostics (CODX) stock based on the movements in the options market lately.
Medical Services Outlook Bright Amid Coronavirus Crisis
by Urmimala Biswas
Despite the coronavirus-led worldwide sales disruption, medical services is one of the few sectors witnessing industry-wide growth right now.
Is Co-Diagnostics (CODX) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (CODX) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Zoom Video, CrowdStrike and Domino's
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Co-Diagnostics, VAXART, Zoom Video, CrowdStrike and Domino's
Co-Diagnostics, Inc. (CODX) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Co-Diagnostics, Inc. (CODX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top Sectors of Q1 & Their Winning Stocks
by Sanghamitra Saha
Inside the top-performing sectors of Q1 and their winning stocks.
Coronavirus Scare Supports These Biotech ETFs & Stocks
by Sanghamitra Saha
Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.
The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Danaher, Quidel, Aytu BioScience, QIAGEN and Co-Diagnostics